<DOC>
	<DOCNO>NCT00260338</DOCNO>
	<brief_summary>Mesenchymal stem cell bone marrow stimulate differentiate endothelial cell participate development new blood vessel ischemic tissue . The aim study phase I/II safety efficacy study evaluate clinical effect autologous mesenchymal stem cell therapy patient severe chronic myocardial ischemia .</brief_summary>
	<brief_title>Stem Cell Therapy Vasculogenesis Patients With Severe Myocardial Ischemia</brief_title>
	<detailed_description>Mesenchymal stem cell bone marrow stimulate differentiate endothelial cell participate development new blood vessel ischemic tissue . The aim study phase I/II safety efficacy study evaluate clinical effect autologous mesenchymal stem cell therapy patient severe chronic myocardial ischemia . 4o patient reversible ischemia SPECT treat direct intramyocardial injection autologous isolate expanded mesenchymal stem cells.Clinical objective evaluation perform baseline 12 month follow-up .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>Age 30 80 year Reversible ischemia stress SPECT Angina pectoris CCS class &gt; _ 2 Reduced exercise time &lt; 10 min No revascularization option Pregnant Present history cancer Proliferative retinopathy Systemic severe disease LVEF &lt; 25 % NYHA &gt; II</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>myocardial ischemia</keyword>
	<keyword>stem cell</keyword>
	<keyword>mesenchymal</keyword>
	<keyword>myocardial perfusion</keyword>
</DOC>